RegeneRx Biopharmaceuticals, Inc. (RGRX)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Apr 14, 2026, 9:30 AM EST
RGRX Market Cap
RGRX has a market cap or net worth of $754 as of April 15, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
754.00
Enterprise Value
n/a
Revenue
76.76K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 16, 1987, RGRX's market cap has decreased from 58.65M to 754.00, a decrease of -100.00%. That is a compound annual growth rate of -25.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 754.00 | 66.45% |
| Dec 31, 2025 | 453.00 | -78.55% |
| Dec 26, 2024 | 2.11K | 16.69% |
| Dec 29, 2023 | 1.81K | -99.99% |
| Dec 30, 2022 | 19.94M | -13.19% |
| Dec 31, 2021 | 22.97M | -61.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Panbela Therapeutics | 971.00 |
| eFFECTOR Therapeutics | 941.00 |
| Alzex Neuropharma | 753.00 |
| Pathfinder Cell Therapy | 667.00 |
| U.S. Stem Cell | 662.00 |
| Nabriva Therapeutics | 646.00 |
| Amarantus BioScience Holdings | 630.00 |
| Virpax Pharmaceuticals | 621.00 |